Sign in to continue:

Tuesday, January 27th, 2026

Singapore Stock Market Update January 2026: Top Equity Picks, Investment News & Analyst Insights

Broker Name: Maybank Research Pte Ltd
Date of Report: 6 January 2026
Excerpt from Maybank Research Pte Ltd report.

Report Summary

  • Sea Ltd’s stock correction is seen as overdone, with a BUY rating and a target price of USD156. Shopee’s strategic investments and Lazada’s decline create a favorable competitive landscape for monetization in ASEAN, offsetting headwinds elsewhere.
  • Singapore’s equity market benefited from increased certainty in ROEs, driven by AI deployment, policy reforms, and rational competition. Winning stocks highlighted include CICT, CD, CSE, GRAB, MLT, OCBC, SGX, SSG, and ST.
  • Positive news includes iFast’s acquisition of a 30% stake in Financial Alliance Corp, signalling growth potential in financial advisory, and Hyphens Pharma’s licensing deal to commercialize its skin cream in six European countries.
  • Singtel is trialing ultra-fast fibre broadband (50Gbps XGS-PON) to support data-intensive environments and future AI-enabled home networks.
  • Insider trade: Helen Chow, wife of Wing Tai’s chairman, increased her stake to 62.34% of the company’s voting shares.
  • The report includes standard disclaimers, disclosure of interests, rating definitions, and legal entity information across Asia, UK, and US, with ratings explained as BUY (>10% expected return), HOLD (0-10%), and SELL (<0%).

Above is an excerpt from a report by Maybank Research Pte Ltd. Clients of Maybank Research Pte Ltd can be the first to access the full report from the Maybank Research website: https://www.maybank.com/

The target price of HK$95.00 is based on 11x FY25F PE, which is below Alibaba’s historical mean of 22x.

Alibaba Group Overview: Share Price: HK$87.20 Target Price: HK$95.00 (Upside of 8.9%) Market Cap: HK$1.677 trillion (~US$212.1 billion) Major Shareholders: Ma Jack Yun (4.5%), Vanguard Group (3.7%), BlackRock (2.6%) Key Updates from the Apsara...

Beng Kuang Marine: Charting New Waters with Asset-Light Agility

Beng Kuang Marine is making waves in the offshore and marine industry, emerging as one of 2024’s standout gainers. Its stock surged an impressive 283.3% over the past year, reaching 22 cents as of...

Raffles Medical Group (RFMD) 1H25 Results: Incremental Growth, China Expansion & 2025 Outlook

CGS International July 29, 2025 Raffles Medical Group: Incremental Growth, China Expansion, and Peer Analysis – A Deep Dive into Asia’s Healthcare Leaders Overview: Modest Growth Amid Insurance Headwinds Raffles Medical Group (RMG) continues...